FDA Updates

New Rx, generics, and OTC

Some tips for keeping these hardworking organs happy and healthy.

New Rx, indications, generics, dosage strengths, and OTC

OTC products designed to support a sleek and youthful appearance

New Rx, new generics, and new OTC

Alternatives for those who sneeze in the spring.

New Rx approvals, new launches, new indications, new formulation, new dosage strengths, new biosimilar, new generics, new OTC

FDA approved Sandoz’s generic version of Copaxone (glatiramer acetate injection) known as Glatopa, making it the first generic version of the drug available for patients with relapsing forms of multiple sclerosis.

Pharmacists who lose touch with the core of their professional identities abandon much more than just activities and functions.

Where does it hurt? Chances are, someone has come up with a treatment for that.

Time to give those babies some love.

New Rx, new generics, new OTC, new devices

A grab bag of products designed to keep those pearly whites in tiptop condition.

New drugs, new generics, new app of interest to pharmacists.

New OTC products offer several approaches to symptom relief.

New drugs, new generics, new OTC

What to do when your innards let you know that you've done too much already.

New Rx, new indications, new generics, new OTC

When wintry weather hurls rain, sleet, snow, and hail straight at our heads, defensive health behaviors start there.

New Rx, generics, and OTC products

Frustrated with the popular dehydration products available, pharmacists Sam and Jamie Lee began searching for alternatives after their 18-month-old son became sick and was in need of rehydration.

New Rx, indications, generics, and OTC products

It's time to tackle the unmentionables.

FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.

It's back-to-school season. Mom and Dad can be losing their hair for a few reasons - finding something crawling on the kids' heads is just the beginning. Here's a host of solutions for parents and their young.

New Rx, indications, generics, and OTC

FDA has approved pembrolizumab (Keytruda, Merck) for treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs. Pembrolizumab, which received breakthrough therapy designation for advanced melanoma, is the sixth new melanoma treatment approved since 2011.